Matches in Nanopublications for { ?s ?p "DDI between Voriconazole and Ethosuximide - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of ethosuximide by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of ambrisentan if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB00593]"@en ?g. }
Showing items 1 to 1 of
1
with 100 items per page.
- drugbank_resource:DB00582_DB00593 label "DDI between Voriconazole and Ethosuximide - Voriconazole, a strong CYP3A4 inhibitor, may increase the serum concentration of ethosuximide by decreasing its metabolism. Monitor for changes in the therapeutic and adverse effects of ambrisentan if voriconazole is initiated, discontinued or dose changed. [drugbank_resource:DB00582_DB00593]" assertion.